tiprankstipranks
Greenwich LifeSciences (GLSI)
NASDAQ:GLSI
US Market
Holding GLSI?
Track your performance easily

Greenwich LifeSciences (GLSI) Ownership - Who Owns Greenwich LifeSciences?

367 Followers

Greenwich LifeSciences (GLSI) Ownership Overview

44.12%3.10%0.14%3.65%48.99%
44.12% Insiders
0.14% Other Institutional Investors
3.65% ETFs
48.99% Public Companies and
Individual Investors
The ownership structure of Greenwich LifeSciences (GLSI) stock is a mix of institutional, retail, and individual investors. Approximately 6.89% of the company’s stock is owned by Institutional Investors, 44.12% is owned by Insiders, and 48.99% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 30, 2024
Snehal Patel
Ceo And Cfo,director, >10% Owner
xxxxxxxxxxxxx
$21945
Sep 16, 2024
Jaye Thompson
Vp Clinical Reg Affairs
xxxxxxxxxxxxx
$11080
Aug 08, 2024
Snehal Patel
Ceo And Cfo,director, >10% Owner
xxxxxxxxxxxxx
$27620
Aug 07, 2024
Snehal Patel
Ceo And Cfo,director, >10% Owner
xxxxxxxxxxxxx
$72490

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,536,102Insider42.12%71,138,911
263,148Insider2.00%3,381,452
258,391Institution1.97%3,320,324
224,770Institution1.71%2,888,295
216,313Institution1.65%2,779,622
63,768Institution0.49%819,419
53,878Institution0.41%692,332
30,268Institution0.23%388,944
16,455Institution0.13%211,447
8,122Institution0.06%104,368

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
224,770Institution1.71%2,888,295
63,768Institution0.49%819,419
53,878Institution0.41%692,332
30,268Institution0.23%388,944
16,455Institution0.13%211,447
8,122Institution0.06%104,368
4,233Institution0.03%54,394
2,755Institution0.02%35,402
1,158Institution<0.01%14,880
805Institution<0.01%10,344

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
153,459Institution1.17%2,064,024
149,930Institution1.14%1,926,601
71,311Institution0.54%959,133
51,081Institution0.39%656,391
27,208Institution0.21%365,948
14,129Institution0.11%181,558
5,630Institution0.04%75,724
3,316Institution0.03%42,345
543Institution<0.01%7,303
547Institution<0.01%6,982

FAQ

Who Owns Greenwich LifeSciences (GLSI)?
According to the latest TipRanks data, approximately 0.14% of the company's stock is held by institutional investors, 44.12% is held by insiders, and 48.99% is held by retail investors.
    What percentage of Greenwich LifeSciences (GLSI) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.14% of Greenwich LifeSciences (GLSI) stock is held by institutional investors.
      What percentage of Greenwich LifeSciences (GLSI) stock is held by retail investors?
      According to the latest TipRanks data, approximately 48.99% of Greenwich LifeSciences (GLSI) stock is held by retail investors.
        Who owns the most shares of Greenwich LifeSciences (GLSI)?
        Snehal Patel owns the most shares of Greenwich LifeSciences (GLSI).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis